Both in vitro and in vivo data confirmed that these nanotheranostic NPs successfully reduced TGF-β expression in tumor cells and markedly boosted the efficacy of temozolomide-mediated chemotherapy [96]. The gene discussed is TGFB1; the disease is neoplasm.